Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MGTX |
---|---|---|
09:32 ET | 1192 | 4.16 |
09:39 ET | 5000 | 4.1301 |
09:43 ET | 100 | 4.13 |
09:50 ET | 100 | 4.13 |
09:56 ET | 100 | 4.115 |
09:59 ET | 100 | 4.11 |
10:08 ET | 100 | 4.11 |
10:10 ET | 347 | 4.09 |
10:15 ET | 100 | 4.085 |
10:24 ET | 100 | 4.07 |
10:33 ET | 100 | 4.07 |
10:35 ET | 100 | 4.075 |
10:53 ET | 500 | 4.1 |
11:02 ET | 899 | 4.12 |
11:22 ET | 453 | 4.1 |
11:24 ET | 200 | 4.1 |
11:29 ET | 200 | 4.09 |
11:38 ET | 592 | 4.105 |
11:56 ET | 100 | 4.13 |
12:02 ET | 100 | 4.13 |
12:03 ET | 331 | 4.125 |
12:05 ET | 577 | 4.13 |
12:09 ET | 200 | 4.13 |
12:25 ET | 200 | 4.11 |
12:27 ET | 100 | 4.11 |
12:30 ET | 816 | 4.125 |
12:39 ET | 100 | 4.11 |
12:41 ET | 400 | 4.125 |
12:43 ET | 100 | 4.125 |
12:54 ET | 300 | 4.12 |
12:56 ET | 100 | 4.11 |
12:57 ET | 1000 | 4.12 |
01:01 ET | 200 | 4.12 |
01:03 ET | 200 | 4.12 |
01:06 ET | 100 | 4.12 |
01:08 ET | 600 | 4.13 |
01:10 ET | 100 | 4.15 |
01:26 ET | 200 | 4.16 |
01:28 ET | 200 | 4.15 |
01:30 ET | 696 | 4.14 |
01:32 ET | 470 | 4.1498 |
01:53 ET | 209 | 4.148 |
01:55 ET | 100 | 4.13 |
02:09 ET | 100 | 4.13 |
02:15 ET | 100 | 4.14 |
02:22 ET | 300 | 4.15 |
02:24 ET | 1307 | 4.14 |
02:36 ET | 100 | 4.14 |
02:44 ET | 1242 | 4.14 |
02:45 ET | 623 | 4.14 |
02:47 ET | 400 | 4.14 |
02:56 ET | 200 | 4.14 |
03:02 ET | 100 | 4.15 |
03:07 ET | 200 | 4.14 |
03:09 ET | 1835 | 4.14 |
03:12 ET | 378 | 4.14 |
03:14 ET | 210 | 4.14 |
03:18 ET | 100 | 4.12 |
03:30 ET | 1633 | 4.13 |
03:34 ET | 519 | 4.14 |
03:36 ET | 900 | 4.14 |
03:38 ET | 300 | 4.14 |
03:43 ET | 100 | 4.13 |
03:48 ET | 400 | 4.15 |
03:50 ET | 412 | 4.15 |
03:52 ET | 100 | 4.14 |
03:54 ET | 1490 | 4.15 |
03:56 ET | 700 | 4.15 |
03:57 ET | 1863 | 4.13 |
03:59 ET | 23990 | 4.15 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
MeiraGTx Holdings PLC | 316.5M | -2.8x | --- |
Iteos Therapeutics Inc | 353.7M | -3.3x | --- |
XOMA Royalty Corp | 309.0M | -12.4x | --- |
TScan Therapeutics Inc | 279.7M | -5.3x | --- |
Inozyme Pharma Inc | 317.4M | -3.5x | --- |
Monte Rosa Therapeutics Inc | 313.6M | -2.3x | --- |
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage gene therapy company. The Company is focused on three distinct areas of unmet medical need: ocular diseases, including inherited retinal diseases (IRDs), as well as large degenerative ocular diseases, severe forms of xerostomia and neurodegenerative diseases. Its product pipeline includes botaretigene sparoparvovec or bota-vec, for the treatment of X-linked retinitis pigmentosa related to mutations in the retinitis pigmentosa GTPase regulator gene or XLRP-RPGR; AAV-hAQP1 for the treatment of radiation-induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-asociated retinal dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of achromatopsia; AAV-AIPL1 for the treatment of LCA4, and AAV-RDH12 for the treatment of RDH12 mutation-associated retinal dystrophy.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $316.5M |
---|---|
Revenue (TTM) | $8.1M |
Shares Outstanding | 77.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.29 |
EPS | $-1.49 |
Book Value | $2.17 |
P/E Ratio | -2.8x |
Price/Sales (TTM) | 39.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,083.19% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.